Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1
- PMID: 29858173
- DOI: 10.1136/annrheumdis-2018-213677
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1
Keywords: autoimmunity; multidisciplinary team care; systemic lupus erythematosus.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1' by Michot et al and 'Checkpoint inhibitor-associated immune arthritis' by Arnaud et al.Ann Rheum Dis. 2019 Jul;78(7):e69. doi: 10.1136/annrheumdis-2018-213691. Epub 2018 Jun 22. Ann Rheum Dis. 2019. PMID: 29934372 No abstract available.
Comment on
-
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
